Kriti Nutrients Limited (IN:KRITINUT)
:KRITINUT
Want to see IN:KRITINUT full AI Analyst Report?
Top Page
Kriti Nutrients Limited
(KRITINUT)
Select Model
Select Model
Rating:80Outperform
Price Target:
₹93.00
▲(18.32% Upside)
Action:Reiterated
Date:05/08/26
The score is driven by strong financial stability (low leverage) and materially improved cash generation, supported by bullish technical trend signals. Valuation also helps due to a low P/E, while the main risk tempering the score is the significant compression in gross and net margins.
Positive Factors
Conservative balance sheet
Very low debt-to-equity (~0.04) and equity growth (₹2.29B in 2026 vs ₹1.32B in 2023) provide durable financial flexibility. This reduces default risk, supports counter-cyclical investment, and preserves capacity to fund capex or absorb commodity shocks without needing external financing.
Negative Factors
Material margin compression
Sharp fall in gross and net margins signals structural pressure on the crush/refining spread or reduced pricing power. Sustained lower margins erode return on capital, limit reinvestment ability, and heighten sensitivity to input-cost spikes in a commodity-driven business.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Very low debt-to-equity (~0.04) and equity growth (₹2.29B in 2026 vs ₹1.32B in 2023) provide durable financial flexibility. This reduces default risk, supports counter-cyclical investment, and preserves capacity to fund capex or absorb commodity shocks without needing external financing.
Read all positive factors
Kriti Nutrients Limited (KRITINUT) vs. iShares MSCI India ETF (INDA)
Market Cap
₹4.25B
Dividend Yield0.43%
Average Volume (3M)2.44K
Price to Earnings (P/E)8.0
Beta (1Y)1.67
Revenue Growth25.49%
EPS Growth-8.35%
CountryIN
Employees230
SectorConsumer Defensive
Sector Strength42
IndustryPackaged Foods
Share Statistics
EPS (TTM)6.30
Shares Outstanding50,103,520
10 Day Avg. Volume4,941
30 Day Avg. Volume2,442
Financial Highlights & Ratios
PEG Ratio-0.93
Price to Book (P/B)1.18
Price to Sales (P/S)0.29
P/FCF Ratio4.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kriti Nutrients Limited Business Overview & Revenue Model
Company Description
Kriti Nutrients Limited engages in the manufacture and sale of soyabean seeds under the Kriti brand in India and internationally. It offers edible oils, such as refined sunflower oil, soya bean oil, filtered groundnut oil, and mustard oil; soya le...
How the Company Makes Money
Kriti Nutrients Limited primarily makes money by processing agricultural oilseeds and selling the resulting outputs across multiple product streams: (1) Edible oils: revenue is generated from selling refined and/or processed edible oils to wholesa...
Kriti Nutrients Limited Financial Statement Overview
Summary
Income Statement
68
Positive
Balance Sheet
86
Very Positive
Cash Flow
78
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.15B | 9.22B | 7.34B | 6.83B | 7.96B | 7.51B |
| Gross Profit | 890.11M | 748.03M | 1.03B | 1.07B | 780.37M | 679.84M |
| EBITDA | 486.40M | 434.39M | 557.89M | 666.67M | 356.28M | 222.83M |
| Net Income | 315.50M | 339.01M | 369.94M | 452.87M | 207.98M | 123.05M |
Balance Sheet | ||||||
| Total Assets | 2.56B | 2.73B | 2.38B | 2.09B | 1.93B | 1.68B |
| Cash, Cash Equivalents and Short-Term Investments | 521.26M | 622.12M | 265.85M | 210.43M | 190.38M | 37.16M |
| Total Debt | 59.08M | 91.01M | 30.69M | 121.45M | 403.73M | 375.58M |
| Total Liabilities | 271.89M | 435.96M | 259.39M | 325.25M | 607.00M | 554.76M |
| Stockholders Equity | 2.29B | 2.29B | 2.12B | 1.76B | 1.32B | 1.13B |
Cash Flow | ||||||
| Free Cash Flow | 397.30M | 642.82M | 273.10M | 409.62M | 133.43M | -193.72M |
| Operating Cash Flow | 427.15M | 698.45M | 319.58M | 498.13M | 198.61M | -105.10M |
| Investing Cash Flow | -321.63M | -152.65M | -288.64M | -291.87M | -31.35M | -199.81M |
| Financing Cash Flow | 13.72M | -100.33M | -106.49M | -304.01M | -14.05M | 311.86M |
Kriti Nutrients Limited Technical Analysis
Negative
78.60
Price Trends
76.77
Positive
74.36
Positive
81.68
Negative
Market Momentum
1.57
Positive
40.84
Neutral
7.88
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:KRITINUT, the sentiment is Negative. The current price of 78.6 is below the 20-day moving average (MA) of 93.08, above the 50-day MA of 76.77, and below the 200-day MA of 81.68, indicating a neutral trend. The MACD of 1.57 indicates Positive momentum. The RSI at 40.84 is Neutral, neither overbought nor oversold. The STOCH value of 7.88 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:KRITINUT.
Kriti Nutrients Limited Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ₹4.25B | 7.96 | ― | 0.43% | 25.49% | -8.35% | |
74 Outperform | ₹68.86B | 14.40 | ― | ― | 23.14% | 50.41% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ₹1.90B | 39.81 | ― | ― | 72.12% | -25.75% | |
57 Neutral | ₹1.35B | 11.68 | ― | ― | 32.25% | 71.27% | |
56 Neutral | ₹6.83B | 10.63 | ― | ― | 44.02% | 12.33% | |
54 Neutral | ₹4.06B | 18.03 | ― | ― | 17.22% | 90.29% |
* Consumer Defensive Sector Average
IN:KRITINUT
Kriti Nutrients Limited
84.74
-29.50
-25.82%
IN:GOKUL
Gokul Refoils & Solvent Ltd.
41.00
-4.15
-9.19%
IN:GOKULAGRO
Gokul Agro Resources Ltd.
233.35
108.75
87.28%
IN:MKPL
M K Proteins Limited
5.05
-2.05
-28.87%
IN:MUKKA
Mukka Proteins Limited
22.75
-8.03
-26.09%
IN:ROML
Raj Oil Mills Limited
45.10
-1.61
-3.45%
Kriti Nutrients Limited Corporate Events
Kriti Nutrients Publishes Audited FY 2026 Results in Newspapers
May 7, 2026
Kriti Nutrients Limited has published its audited standalone and consolidated financial results for the quarter and full year ended 31 March 2026, and has filed the related newspaper clippings with the stock exchanges. The disclosure, made through...
Kriti Nutrients Files FY26 Audited Results and Financial Statements
May 5, 2026
Kriti Nutrients Limited has submitted its standalone and consolidated audited financial results for the year ended 31 March 2026 to the stock exchange, along with the accompanying audit report, statement of assets and liabilities, and cash flow st...
Kriti Nutrients updates Memorandum of Association after EGM approval
Mar 23, 2026
Kriti Nutrients Limited has notified the stock exchanges that shareholders approved and adopted a revised Memorandum of Association at an Extraordinary General Meeting held on 20 March 2026 in Indore. The amendment includes the insertion of a new ...
Kriti Nutrients Updates Articles of Association After Shareholder Approval
Mar 23, 2026
Kriti Nutrients Limited has notified the stock exchanges that shareholders approved and adopted a new set of Articles of Association at an Extraordinary General Meeting held on 20 March 2026. The changes include the insertion of a new Article 92 a...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.